These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 11337927

  • 1. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
    Mukawa H, Sone T, Tsuboi H, Kondo J, Kosokabe T, Uesugi M, Imai H.
    J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of low-dose mutant tissue-type plasminogen activator followed by planned rescue percutaneous transluminal coronary angioplasty as reperfusion therapy for acute myocardial infarction].
    Tsukahara K, Kimura K, Usui T, Okuda J, Kitamura Y, Kosuge M, Sano T, Tohyama S, Nemoto T, Yamanaka O, Yoshii Y, Tochikubo O, Umemura S.
    J Cardiol; 2001 Mar; 37(3):143-50. PubMed ID: 11281054
    [Abstract] [Full Text] [Related]

  • 3. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F.
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of thrombolytic therapy and direct percutaneous transluminal coronary angioplasty for acute myocardial infarction: prospective multicenter trial at 16 clinical centers in Ibaraki prefecture TUGMI. Tsukuba University Group for Myocardial Infarction].
    Noguchi Y, Yamaguchi I, Sugishita Y.
    J Cardiol; 1996 Mar; 27(3):111-20. PubMed ID: 8865683
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C, Rossetti G, Vado A, Racca E, Steffenino G, Dellavalle A, Ribichini F, Ferrero V, Menardi E, Uslenghi E.
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of left ventricular aneurysm formation and left ventricular remodeling caused by percutaneous transluminal coronary angioplasty performed 24-48 hours after onset of acute myocardial infarction].
    Kanamasa K, Ogawa I, Koka H, Ishida N, Sasaki T, Nakabayashi T, Nakagawa K, Takada K, Kato H, Otani N, Ishikawa K, Katori R.
    J Cardiol; 1996 Oct; 28(4):199-205. PubMed ID: 8934335
    [Abstract] [Full Text] [Related]

  • 7. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.
    Kurihara H, Matsumoto S, Tamura R, Yachiku K, Nakata A, Nakagawa T, Yoshino T, Matsuyama T.
    Am Heart J; 2004 Apr; 147(4):E14. PubMed ID: 15077097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Percutaneous transluminal coronary angioplasty for treatment of acute myocardial infarction: comparison with percutaneous transluminal coronary recanalization].
    Goto T, Mitsudo K, Matsunaga K, Doi O, Nishihara Y, Awa J, Hase T, Sakamoto T, Toda M, Kou E.
    J Cardiol; 1989 Jun; 19(2):375-85. PubMed ID: 2636619
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ.
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [Abstract] [Full Text] [Related]

  • 19. [Direct percutaneous transluminal coronary angioplasty (PTCA) for treatment of acute myocardial infarction: comparison with PTCA immediately after thrombolysis].
    Oka Y, Yoshida O, Kajiyama M, Masuoka T, Ito Y, Kawagoe T, Nagao H, Tsuchiya T.
    J Cardiol; 1989 Jun; 19(2):365-73. PubMed ID: 2636618
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM, Pasquale PD, D'Alfonso G, Amerigo L, Cannizzaro S, Castello A.
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.